Semaglutide and Cardiovascular Outcomes in Patients With Overweight or Obesity Who Do Not Have Diabetes

被引：0
|
作者：
Lincoff, Abraham M. [1 ]
Brown-Frandsen, Kirstine [2 ]
Colhoun, Helen M. [3 ]
Deanfield, John [4 ]
Emerson, Scott S. [5 ]
Esbjerg, Sille [6 ]
Hardt-Lindberg, Soren [7 ]
Hovingh, G. Kees [8 ]
Kahn, Steven E. [9 ,10 ]
Kushner, Robert F. [11 ]
Lingvay, Ildiko [12 ]
Oral, Tugce Kalayci [8 ]
Michelsen, Marie M. [13 ]
Plutzky, Jorge [14 ]
Tornoee, Christoffer W. [15 ]
Ryan, Donna H. [16 ]
机构：
[1] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44106 USA
[2] Novo Nordisk AS, Business Dev, Soborg, Denmark
[3] Univ Edinburgh, Inst Genet & Canc, Edinburgh, Midlothian, Scotland
[4] UCL, Dept Clin Sci, London, England
[5] Univ Washington, Dept Biostat, Seattle, WA 98195 USA
[6] Novo Nordisk AS, Dept Biostat, Soborg, Denmark
[7] Novo Nordisk AS, Project Management CKAD 5, Soborg, Denmark
[8] Novo Nordisk AS, Global Med Affairs, Soborg, Denmark
[9] VA Puget Sound Hlth Care Syst, Dept Med, Seattle, WA USA
[10] Univ Washington, Seattle, WA 98195 USA
[11] Northwestern Univ, Dept Med & Med Educ, Chicago, IL 60611 USA
[12] UT SouthWestern Med Ctr, Dept Internal Med Endocrinol, Dallas, TX USA
[13] Novo Nordisk AS, Med & Sci, Soborg, Denmark
[14] Harvard Med Sch, Brigham & Womens Hosp, Cardiovasc Med Div, Boston, MA 02115 USA
[15] Novo Nordisk AS, Obes Liver Dis & Devices, Soborg, Denmark
[16] Pennington Biomed Res Ctr, Clin Res, 6400 Perkins Rd, Baton Rouge, LA 70808 USA
来源：
CIRCULATION | 2023年 / 148卷 / 25期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
22962
引用
收藏
页码：E283 / E283
页数：1
相关论文
共 50 条
  • [21] The cost-effectiveness of semaglutide in reducing cardiovascular risk among people with overweight and obesity and existing cardiovascular disease, but without diabetes
    Zomer, Ella
    Zhou, Jennifer
    Nelson, Adam J.
    Sumithran, Priya
    Nanayakkara, Shane
    Ball, Jocasta
    Kaye, David
    Liew, Danny
    Nicholls, Stephen J.
    Stub, Dion
    Zoungas, Sophia
    EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 2024,
  • [22] Cardiovascular effects of semaglutide in patients with HFpEF and obesity
    Dahm, Johannes B.
    AKTUELLE KARDIOLOGIE, 2024, 13 (01) : 18 - 18
  • [23] Semaglutide for the secondary prevention of cardiovascular disease in people with overweight or obesity, but without diabetes: a cost-effectiveness analysis
    Zomer, E.
    Zhou, J.
    Nelson, A. J.
    Nicholls, S. J.
    Stub, D.
    Zoungas, S.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [24] Semaglutide for the secondary prevention of cardiovascular disease in people with overweight or obesity, but without diabetes: a cost-effectiveness analysis
    Zomer, E.
    Zhou, J.
    Nelson, A. J.
    Nicholls, S. J.
    Stub, D.
    Zoungas, S.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [25] Real World Weight Loss Outcomes of Semaglutide in Patients With Overweight and Obesity After Bariatric Surgery
    Ghusn, Wissam
    Gala, Khushboo S.
    De La Rossa, Alan
    Cifuentes, Lizeth
    Sacoto, Daniel
    Campos, Alejandro
    Feris, Fauzi
    Hurtado, Maria D.
    Acosta, Andres
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S1044 - S1045
  • [26] Semaglutide and Cardiovascular Outcomes by Baseline HbA1c and Change in HbA1c in People With Overweight or Obesity but Without Diabetes in SELECT
    Lingvay, Ildiko
    Deanfield, John
    Kahn, Steven E.
    Weeke, Peter E.
    Toplak, Hermann
    Scirica, Benjamin M.
    Ryden, Lars
    Rathor, Naveen
    Plutzky, Jorge
    Morales, Cristobal
    Lincoff, A. Michael
    Lehrke, Michael
    Jeppesen, Ole Kleist
    Gajos, Grzegorz
    Colhoun, Helen M.
    Cariou, Bertrand
    Ryan, Donna
    DIABETES CARE, 2024, 47 (08)
  • [27] Meta-Analysis Assessing the Cardiovascular Safety of Semaglutide for the Treatment of Overweight or Obesity
    Bavishi, Chirag
    Trivedi, Vrinda
    Bhatt, Deepak L.
    AMERICAN JOURNAL OF CARDIOLOGY, 2022, 175 : 182 - 184
  • [28] Semaglutide Improves Cardiovascular Outcomes in Patients With History of Coronary Artery Bypass Graft and Obesity
    Verma, Subodh
    Emerson, Scott
    Plutzky, Jorge
    Kahn, Steven E.
    Stensen, Signe
    Weeke, Peter E.
    Musinga, Derrick
    Poirier, Paul
    Lingvay, Ildiko
    Lincoff, A. Michael
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2025, 85 (05) : 541 - 545
  • [29] Oral Semaglutide and Cardiovascular Outcomes in Type 2 Diabetes
    Zweck, Elric
    Westenfeld, Ralf
    Szendroedi, Julia
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (21): : 2075 - 2076
  • [30] Clinical outcomes of patients with gestational diabetes mellitus who do not have typical risk factors
    Nijjar, S. K.
    Hunt, K. F.
    Rogers, H.
    Smith, C.
    Gayle, C. M.
    Marsh, M. S.
    Amiel, S. A.
    Choudhary, P.
    DIABETOLOGIA, 2011, 54 : S479 - S480
12345